| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |